Role of radiotherapy in the tretment of superior vena cava syndrome caused by lung cancer

S. S. Vucicevic, N. P. Jovanovic-Korda, G. A. Gligorijevic (Belgrade, Serbia & Montenegro)

Source: Annual Congress 2004 - Complications of lung cancer or its treatment quality of life - prognosis
Session: Complications of lung cancer or its treatment quality of life - prognosis
Session type: Thematic Poster Session
Number: 572
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. S. Vucicevic, N. P. Jovanovic-Korda, G. A. Gligorijevic (Belgrade, Serbia & Montenegro). Role of radiotherapy in the tretment of superior vena cava syndrome caused by lung cancer. Eur Respir J 2004; 24: Suppl. 48, 572

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Surgical treatment of superior vena cava syndrome caused by thymic carcinoma
Source: Annual Congress 2012 - Mediastinum and tracheobronchial tree
Year: 2012


Lung cancer patients with vena cava superior syndrom
Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology
Year: 2008

The effect of superior vena cava dose radiotherapy on dyspnea among patients with superior vena cava syndrome: Philippine general hospital experience
Source: Annual Congress 2007 - Lung neoplasms
Year: 2007


Electrocardiographic changes in patients with bronchial carcinoma and syndrome of vena cava superior (SVCS)
Source: Eur Respir J 2001; 18: Suppl. 33, 66s
Year: 2001

Superior vena cava obstruction and non-small cell lung cancer: stent as gold-standard?
Source: Eur Respir J 2003; 22: Suppl. 45, 433s
Year: 2003

Minimally invasive procedures in superior vena cava syndrome
Source: Eur Respir J 2005; 26: Suppl. 49, 678s
Year: 2005

Diagnostic approach to superior vena cava syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 273s
Year: 2004

Prognostic factors to survival in patients with lung cancer and superior vena cava syndrome: A retrospective analysis
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016


Efficacy and safety of inferior vena cava filters in patients with surgically treated chronic thromboembolic pulmonary hypertension
Source: International Congress 2019 – Epidemiology and management of acute pulmonary embolism
Year: 2019

Performance and safety of endoscopic procedures in superior vena cava syndrome
Source: Virtual Congress 2020 – Management issues in thoracic oncology
Year: 2020


Evaluation of minimally invasive procedures and a diagnostic algorithm for superior vena cava syndrome
Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology
Year: 2008


Retrospective analysis of patients with superior vena cava syndrome (SVCS)
Source: Eur Respir J 2003; 22: Suppl. 45, 253s
Year: 2003

Performance and safety of diagnostic procedures in superior vena cava syndrome
Source: ERJ Open Res, 7 (1) 00392-2020; 10.1183/23120541.00392-2020
Year: 2021



Pleural transudate: pathophysiology during superior vena cava syndrome
Source: ERJ Open Res, 5 (1) 00251-2018; 10.1183/23120541.00251-2018
Year: 2019



Endovascular stenting of superior vena cava syndrom
Source: Eur Respir J 2006; 28: Suppl. 50, 754s
Year: 2006

Superior vena cava syndrome induced by bronchogenic carcinoma: the use of radiotherapy, chemotherapy and Gianturco self-expanding stent
Source: Eur Respir J 2001; 18: Suppl. 33, 395s
Year: 2001

Superior vena cava syndrome secondary to tuberculous mediastinitis
Source: Eur Respir J 2002; 20: Suppl. 38, 367s
Year: 2002

Superior vena cava syndrome caused by tuberculosis of the mediastinal lymph nodes. A particular clinical case
Source: Annual Congress 2010 - Clinical tuberculosis
Year: 2010

Clinical and radiological grading of superior vena cava obstruction
Source: Eur Respir J 2006; 28: Suppl. 50, 59s
Year: 2006